IRadimed Corporation IRMD
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 18.26% | -6.88% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 18.26% | -6.88% | |||
| Cost of Revenue | 8.31% | 2.73% | |||
| Gross Profit | 21.74% | -9.84% | |||
| SG&A Expenses | 16.40% | -5.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.13% | -4.52% | |||
| Operating Income | 27.35% | -11.69% | |||
| Income Before Tax | 25.84% | -11.34% | |||
| Income Tax Expenses | 29.46% | -14.40% | |||
| Earnings from Continuing Operations | 24.68% | -10.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 24.68% | -10.31% | |||
| EBIT | 27.35% | -11.69% | |||
| EBITDA | 25.73% | -11.58% | |||
| EPS Basic | 24.64% | -10.31% | |||
| Normalized Basic EPS | 25.84% | -11.37% | |||
| EPS Diluted | 24.64% | -9.29% | |||
| Normalized Diluted EPS | 25.81% | -11.37% | |||
| Average Basic Shares Outstanding | 0.02% | 0.01% | |||
| Average Diluted Shares Outstanding | 0.03% | 0.02% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.20% | 0.12% | |||